MI can be diagnosed by?

BSF Staff Nurse - 2021

Medical Surgical Nursing

Hard

Appeared in: BSF Staff Nurse - 2021

Explanation

The diagnosis of Myocardial Infarction (MI) is a clinical process that integrates multiple sources of information, not just a single test.
ECG is a fundamental first step to detect electrical changes in the heart indicative of ischemia or infarction, such as ST-segment elevation.
Cardiac biomarkers, like CPK-MB and historically LDH, are released from necrotic heart muscle, providing biochemical evidence of myocardial damage.
Although the option 'LDH amylase' is flawed due to the inclusion of amylase (a pancreatic enzyme), the question intends to test the knowledge that ECG, CPK-MB, and LDH are all part of the diagnostic picture for MI, making 'All the above' the most encompassing answer.

Option A: Choosing only ECG is incomplete. While crucial for initial diagnosis and classification (STEMI vs. NSTEMI), some MIs (NSTEMI) may have non-specific or no ECG changes. Biomarkers are required for confirmation.
Option B: Choosing only CPK-MB is insufficient. Diagnosis requires correlation with clinical symptoms and ECG findings. Also, CPK-MB is less sensitive and specific than the current gold-standard, Troponin.
Option C: This option is incorrect because amylase is not a cardiac marker; it is related to the pancreas. LDH is a non-specific and outdated marker for MI, largely replaced by troponins.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Diagnostic markers for Myocardial Infarction (MI) as background academic context rather than a clinical decision trigger.
A nurse's primary role in a suspected MI is rapid assessment and intervention. This includes obtaining a 12-lead ECG within 10 minutes of patient arrival, drawing blood for cardiac biomarkers (especially troponin), administering initial medications like aspirin, and continuously monitoring the patient's vital signs and pain level.
Understanding the different timelines of cardiac markers is crucial. For example, an initial negative troponin test does not rule out an MI; serial testing (e.g., at 0, 3, and 6 hours) is standard protocol to detect a rise in levels.
What if? If a patient presents with chest pain 5 days after it started, both CPK-MB and Troponin I might be returning to normal or be at low levels, but LDH (and Troponin T) would likely still be elevated, making it potentially useful in this specific late-presentation scenario.

How to Approach the Question

First, identify the core concept of the question, which is the diagnosis of Myocardial Infarction (MI).
Evaluate each option's relevance to diagnosing MI. You should recognize ECG and CPK-MB as standard diagnostic tools.
Critically assess the 'LDH amylase' option. Identify that LDH is a historical marker for MI, but amylase is incorrect. This indicates a potential flaw in the question.
Consider the option 'All the above'. When multiple individual options are correct (or part of the diagnostic process) and 'All the above' is available, it is often the intended answer, representing a comprehensive approach.
Synthesize the information: Since MI diagnosis involves ECG and biomarkers (like CPK-MB and historically LDH), the 'All the above' option, despite its flaw, encompasses the multifaceted nature of the diagnostic process.

Concept Tested & Keywords

QiFugrzIpA-YJUaKgnrRrL

E6 PATHOLOGY QUICK REVIEWBased on Harsh Mohan Textbook of PATHOLOGY p. 196-198

E6 Pathology-Textbook of PATHOLOGYHarsh Mohan Part 2 (215-514) p. 9-11